Female patients | Â | DAH30 | ||
 |  |  > 10th percentile |  ≤ 10th percentile | Total |
 DAH90 |  > 10th percentile | 19,630 (97.6%) | 429 (19.9%) | 20,059 (90.1%) |
 ≤ 10th percentile | 480 (2.4%) | 1,731 (80.1%) | 2,211 (9.9%) | |
Total | 20,110 (90.3%) | 2,160 (9.7%) | 22,270 (100) | |
 DAH180 |  > 10th percentile | 19,471 (96.8%) | 586 (27.1%) | 20,057 (90.1%) |
 ≤ 10th percentile | 639 (3.2%) | 1,574 (72.9%) | 2,213 (9.9%) | |
Total | 20,110 (90.3%) | 2,106 (9.7%) | 22,270 (100%) | |
Male patients | DAH30 | |||
 > 10th percentile |  ≤ 10th percentile | Total | ||
 DAH90 |  > 10th percentile | 57,385 (98.3%) | 1,234 (19.6%) | 58,619 (90.6%) |
 ≤ 10th percentile | 1,017 (1.7%) | 5,073 (80.4%) | 6,090 (9.4%) | |
Total | 58,402 (90.3%) | 6,307 (9.8%) | 64,709 (100) | |
 DAH180 |  > 10th percentile | 56,783 (97.2%) | 1,508 (23.9%) | 58,291 (90.1%) |
 ≤ 10th percentile | 1,619 (2.8%) | 4,799 (76.1%) | 6,418 (9.9%) | |
Total | 58,402 (90.3%) | 6,307 (9.8%) | 64,709 (100%) |